Webinar by Senior Scientist Arnoud Marquart on label-free biosensing

Webinar

Introduction to Label-free Biosensing

We are thrilled to announce an exciting webinar by Senior Scientist Arnoud Marquart on label-free biosensing, a revolutionary approach that enhances kinetics and quantitative measurements for a wide range of biomolecules, from small molecules to antibodies.

In this webinar, we’ll delve into the techniques, applications, and breakthroughs enabled by label-free biosensing and the inQuiQ®, an multiplex label-free biosensing instrument based on integrated photonics.

Agenda of the webinar:

  • The basics of label-free biosensing: Understand the science and its advantages over traditional methods like ELISA.
  • Applications: Learn how label-free detection accelerates drug discovery and biomolecular research.
  • inQuiQ in Action: See how the cutting-edge NES technology makes multiplexed biosensing more accessible and efficient.
  • Live Q&A: Engage with our experts and get your questions answered.

Who should attend?

Scientists, researchers, and innovators looking to explore the potential of label-free biosensing in their work. Feel free to share this invitation with colleagues who might benefit.

When and where?

The first webinar will be held live and online on Tuesday 28 of January, 16:00 CET.

Subscribe now: https://meet.zoho.eu/U0bd8jScmy

Delta Life Science transforms the landscape of biosensing with the launch of inQuiQ®  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 2024, Rotterdam- Delta Life Science, a leader in label-free, multiplexed biosensing, brings inQuiQ® to market. 

 

 

 

 

 

 

 

 

Powered by our Nanophotonic Evanescent field Sensing (NES) technology, the inQuiQ® allows scientists to conduct highly sensitive, multiplexed analyses with sample volumes from 10 µl to 2 ml on a reusable photonic sensor. Taking up only an A3 paper-size space in your laboratory, the compact inQuiQ® gives you real-time data with improved 16-plex measurements in serum, plasma, and supernatant.  

 

 

 

 

 

 

 

 

“The maximum sample volume that can be drawn from mice is about 100 microliters. For our research, we need to maximize what we can measure from these small samples. The highly multiplexed detection technology which is able to measure many different biomolecular interactions simultaneously using minimal sample volumes, is therefore essential for us.” – Prof. Dr. F. Grosveld, Erasmus MC / Harbour Antibodies 

 

 

 

 

 

 

 

 

From drug development to food safety, studying the interaction of any combination of biomolecules, the applications of the inQuiQ® instrument are designed for customizable assays regardless of the life sciences field you are in.  

 

 

 

 

 

 

 

 

What’s in store for 2025? 

 

 

 

 

 

 

 

 

If your need for throughput has increased, Delta Life Science will launch its second instrument, the inQuiQ® 768 in 2025. The add-on to the base model integrates an autosampler, enabling the analysis of two well plates in one run. Additionally, a GxP version will be available, compliant with 21 CFR pt. 11 regulations.  

 

 

 

 

 

 

 

 

Discover how inQuiQ® can enhance your analysis. 

 

 

 

 

 

 

 

 

About Delta Life Science   

 

 

 

 

 

 

 

 

Delta Life Science, headquartered in Rotterdam, The Netherlands, is committed to revolutionizing biosensing technology by making label-free, multiplexed biosensors and instruments accessible to all. The company’s innovative approach to biosensing, using photonic integrated circuits, reduces the complexity and cost of traditional lab methods. By providing a rapid, sensitive, low-cost solution, Delta Life Science aims to empower researchers and industry professionals to make groundbreaking advancements in Life Sciences.   

 

 

 

 

 

 

 

 

Press Contact  

 

 

 

 

 

 

 

 

Bart Stenneken, Delta Life Science   

 

 

 

 

 

 

 

 

mobile +31615463508 

 

 

 

 

 

 

 

 

email bart.stenneken@deltalifescience.nl 

 

 

 

 

Download the DNA-Protein Interactions’ whitepaper

This white paper demonstrated capture of a biotinylated oligonucleotide using a streptavidin modified surface. Subsequently, kinetic measurements were performed demonstrating that the oligonucleotide can bind DNA-binding proteins. The streptavidin modification highlights the platform as a cost-effective and sensitive option for biomolecular interactions, benefiting the life science research community.

Download the Small Molecule Kinetics whitepaper

The inQuiQ™ instrument uses a unique optical technology with ring-resonators to achieve precise molecular binding measurements. This facilitates real-time, label-free analysis of biomolecular interactions. This white paper displays effectiveness of the instrument in kinetic analysis of biomolecule interactions using Carbonic Anhydrase II (CAII) and compound interaction as a model system

Download the High-Throughput Analysis whitepaper

The inQuiQ™ instrument uses unique optical technology with ring-resonators for precise molecular binding measurements, facilitating real-time, label-free analysis of biomolecular interactions. This white paper demonstrates the instrument’s effectiveness in high-throughput analysis of the association of biomolecules. This highlights the instrument as a cost-effective and sensitive option for rapid quantitation, making advanced research on biomolecular interactions more accessible to the life science research community.

Download the Chip Reusability and Stability whitepaper

The inQuiQ™ instrument using unique optical technology with ring-resonators for precise molecular binding measurements facilitates real-time, label-free analysis of biomolecular interactions. This white paper demonstrates the reusability and stability of the sensor chips. Effectiveness in repetitive analysis of biomolecule interactions is shown using rabbit IgG as ligand and anti-rabbit IgG as analyte. It highlights the instrument as a cost-effective and sensitive option for analysis of biomolecules, making advanced research on biomolecular interactions accessible for all.